Process of diseased tau assembly into neurofibrillary structures differs in Alzheimer's disease and other tauopathies

被引：0
|
作者：
Zilkova, M
Vechterova, L
Konstekova, E
Konstek, P
Novak, M
机构：
[1] Inst Neuroimmunol, Bratislava, Slovakia
[2] Axon Neurosci, Vienna, Austria
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81384-8
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S421 / S421
页数：1
相关论文
共 50 条
  • [21] Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors
    Brunden, Kurt R.
    Ballatore, Carlo
    Crowe, Alex
    Smith, Amos B., III
    Lee, Virginia M-Y
    Trojanowski, John Q.
    EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 304 - 310
  • [22] Tau protein and the neurofibrillary pathology of Alzheimer's disease
    Goedert, M
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 121 - 131
  • [23] The Genetics of Alzheimer's Disease and Other Tauopathies
    Hardy, John
    Guerreiro, Rita
    Wray, Selina
    Ferrari, Raffaele
    Momeni, Parastoo
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 23 : S33 - S39
  • [24] Tau in Alzheimer Disease and Related Tauopathies
    Iqbal, K.
    Liu, F.
    Gong, C. -X.
    Grundke-Iqbal, I.
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (08) : 656 - 664
  • [25] Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies
    Abey, Ajantha
    Davies, Danielle
    Goldsbury, Claire
    Buckland, Michael
    Valenzuela, Michael
    Duncan, Thomas
    BRAIN PATHOLOGY, 2021, 31 (01) : 144 - 162
  • [26] Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
    Simic, Goran
    Leko, Mirjana Babic
    Wray, Selina
    Harrington, Charles
    Delalle, Ivana
    Jovanov-Milosevic, Natasa
    Bazadona, Danira
    Buee, Luc
    de Silva, Rohan
    Di Giovanni, Giuseppe
    Wischik, Claude
    Hof, Patrick R.
    BIOMOLECULES, 2016, 6 (01) : 2 - 28
  • [27] Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies
    Schroeder, Sulana K.
    Joly-Amado, Aurelie
    Gordon, Marcia N.
    Morgan, Dave
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (01) : 9 - 25
  • [28] Whole CNS Human Tau Knockdown for the Potential Treatment of Alzheimer's Disease and Other Tauopathies
    Zeitler, Bryan J.
    Marlen, Kimberly
    Ojala, David
    Ledeboer, Annemarie
    Yu, Qi
    Pan, Yonghua
    Cisbani, Giulia
    Peters, Finn
    Melis, Chiara
    Tiffany, Matthew R.
    Mueller, Sarah
    Kennard, Kenneth
    Dunn, Patrick
    Hoang-Oanh Nguyen
    Hung Tran
    Meyer, Kathleen
    Pooler, Amy
    MOLECULAR THERAPY, 2024, 32 (04) : 535 - 535
  • [29] Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies
    Annadurai, Narendran
    De Sanctis, Juan B.
    Hajduch, Marian
    Das, Viswanath
    EXPERIMENTAL NEUROLOGY, 2021, 343
  • [30] Specific modifications of the soluble tau protein distinguish Alzheimer's disease from other tauopathies
    Zola, Nathalie Kyalu Ngoie
    Balty, Clemence
    Vertommen, Didier
    Hanseeuw, Bernard Jimmy
    M S-MEDECINE SCIENCES, 2024, 40 (04): : 328 - 331
12345